Part 2 of 3 — Eloralintide vs. Cagrilintide In Part 1, we introduced Eloralintide and discussed how it works through the amylin pathway to help regulate appetite and food intake. We ended with a simple question: If Eloralintide sounds so much like Cagrilintide, what's actually different? At first glance, not much. Both compounds mimic the body's natural amylin hormone, help people feel full sooner, help people stay full longer, slow gastric emptying and support weight management through appetite regulation. In fact, if someone were describing the two compounds without naming them, most people would probably assume they were talking about the same thing. → Then it still begs the question: Why Eloralintide? While both compounds target the amylin pathway, Eloralintide is being engineered to be highly selective for amylin receptors, aiming to maximize the desired amylin effects while reducing the potential for certain bone-related side effects. The fundamental differences lie in molecular design and the quality of weight loss—specifically regarding muscle mass. One area researchers have been paying close attention to is body composition. Most people think of weight loss as a single number on a scale. → The body doesn't see it that way. The body is reacting to the dietary environment you create. Your body is constantly adapting to the environment you create through diet, protein intake, activity level, and recovery. If those pieces (Macros) are not in place, the body may obtain what it needs from wherever it can. The goal isn't simply losing weight. The goal is losing fat while preserving lean muscle mass. Ideally, we want as much of that loss as possible to come from fat. That's where Eloralintide has generated attention. Early research suggests Eloralintide may preserve a greater percentage of lean mass while directing more of the total weight loss toward fat tissue compared with Cagrilintide. The discussion may know focus more losing better weight from fats.

This one is worth paying attention to. Eli Lilly filed six lawsuits today targeting companies selling retatrutide in the United States. Retatrutide is still an investigational drug in Phase 3 clinical trials and is not currently FDA-approved for human use. But that isn't really the most interesting part of this story. Four of the companies Lilly is suing are peptide sellers marketing retatrutide as “Research Use Only.” The lawsuits include: • Astra Peptides • Legendary Peptides • Texas Peptides • Lone Star Peptide • Aesthetic Envy — a California med spa • Striker Pharmacy — a compounding pharmacy According to Lilly, some sellers are using a “Research Use Only” designation while actually marketing or supplying the product for human use. But Lilly is going much further than six lawsuits. The company is publicly calling on: Social-media platforms Payment processors Credit-card companies E-commerce platforms Shipping and logistics companies Regulators and law enforcement to help disrupt what Lilly calls the illegal retatrutide market. That is what caught my attention. This isn't simply Lilly sending cease-and-desist letters to a few websites. They are signaling an effort to attack the infrastructure that allows the market to operate. Why Retatrutide? Follow the economics. Retatrutide is one of Lilly's most important next-generation obesity drugs. Clinical development is well advanced, results have generated enormous interest, and Lilly has said it intends to seek regulatory approval beginning in early 2027. At the same time, an enormous unauthorized market already exists for the molecule before Lilly has sold a single approved prescription. So this shouldn't be surprising. But I also wouldn't dismiss it as pharmaceutical-company noise. Retatrutide has now become a sufficiently valuable commercial asset that Lilly is openly escalating enforcement against the market that developed around it before approval. And perhaps most importantly, they aren't only looking at manufacturers and sellers.

Your Body Already Makes This One What Is LL-37? LL-37 is the only member of the cathelicidin peptide family identified in humans. It consists of 37 amino acids and is naturally produced by the body as part of our innate immune defense system — essentially one of the body's first lines of defense when something potentially harmful shows up. But LL-37 is more interesting than simply being an antimicrobial peptide. Research suggests it also plays roles in immune signaling, inflammation, biofilm activity, tissue repair and wound healing. ⚡ 3 Ways LL-37 Impacts the Body — According to Research 1. THE MEMBRANE DISRUPTOR LL-37 can interact directly with microbial membranes. Because of its structure and positive charge, it can bind to certain negatively charged microbial surfaces, destabilizing their membranes and contributing to the destruction of the microorganism. Research has demonstrated activity involving bacteria, fungi and some viruses, although its effectiveness varies considerably depending on the organism and biological environment. 2. THE BIOFILM DISRUPTOR Some microorganisms don't just float around individually. They can organize themselves into biofilms — protective communities surrounded by a matrix that helps shield them from the immune system and can make them much harder to eliminate. LL-37 has been heavily researched for its ability to interfere with biofilm formation and disrupt biofilm behavior in certain experimental models. This is one of the reasons LL-37 gets so much attention in antimicrobial research. 3. THE TISSUE REPAIR CREW This is where LL-37 gets especially interesting. Its role doesn't stop with microbes. Research has associated LL-37 with: Cell migration • Epithelial repair • Angiogenesis • Wound healing • Tissue remodeling In other words, LL-37 appears to participate not only in defending damaged tissue but also in helping coordinate some of the processes involved in repairing it. 🧠 BUT THERE'S ANOTHER SIDE TO LL-37 LL-37 is sometimes casually described as an “immune booster.” A better description is immune modulator.

Back in May, I shared a post titled Joint Relief & The Research Community. In that post, I referenced an injectable joint-support compound being presented as an experimental connective-tissue formulation focused on joint comfort, connective-tissue support, and inflammatory balance. I was personally very interested in researching this blend because I deal with joint deterioration and chronic knee discomfort. Based on my own experience, I have become a strong proponent of this complex. I noticed relief within the first two injections and continued using it for eight weeks. I am currently cycled off, although I honestly do not believe this is necessarily a complex that must be cycled. My workouts can be aggressive and include HIIT sessions involving wall balls, rowing, medicine-ball cleans, and repeated deep knee bends. Normally, I would pay for that activity the following day with increased knee discomfort. Since using Joint Juice, that next-day discomfort has been approximately 70% to 80% lower. For me, that says enough. This is not an inexpensive product, but the benefits I experienced made it well worth the cost. Now that I have stopped using it, I am tracking how long the effects appear to last and when—or if—the discomfort begins returning. I will follow up in a few weeks with an update. The Complex The ingredients are at least mechanistically coherent: - N-Acetyl-D-Glucosamine — NAG - Chondroitin Sulfate - MSM — Methylsulfonylmethane - Glycine My motto remains: Your Body. Your Code. Every person may respond differently based on their own body, condition, activity level, and individual response to the complex. For what it is worth, I strongly recommend researching Joint Juice. For anyone dealing with joint pain or ongoing discomfort, this may be well worth the research effort. If anyone want to pursue obtaining this product please DM me.

Please Read the entire document before placing an order. Shipment Capacity: 0 / 20 Kits Open Kit Spots: 20 Interested in ordering from WWB without absorbing the vendor’s full international shipping charge yourself? WWB charges a fixed $60 international shipping fee, regardless of the total order value. Dark Horse will combine member requests into one vendor order so that the shipping charge can be divided equally among all participating members. WWB consolidated orders will operate on a 7- to 14-day ordering cycle and will close once the shipment reaches 20 total kits or the cycle ends, whichever occurs first. There is no minimum order per person. At closing, Dark Horse will reconfirm current pricing and product availability with WWB before final invoices are issued. Each shipment will remain limited to 20 kits to help keep the customs package size controlled. WWB Product Listing The WWB member price sheet includes available products, strengths, and pricing. On the order form, enter the exact: - Product - Strict - Quantity - Current listed price WWB Product Listing: https://docs.google.com/spreadsheets/d/1oREQ9g-lZ5xtngTPUSX3KZp4Sgx9EScy/edit?usp=sharing&ouid=109707448490722541182&rtpof=true&sd=true WWB Order Form: https://docs.google.com/forms/d/e/1FAIpQLSfglHmWL-kfGshTUIyRNhrT7q_NBQMaAkSsTGwukLHXxuCx8g/viewform?usp=publish-editor WWB Independent Third-Party COAs WWB maintains a Dropbox containing all independent third-party COAs it has made available. These include reports commissioned by the vendor as well as reports supplied by its clients. Independent third-party documentation is not available for every product listed. The presence of a report also does not establish that it represents the current inventory, lot, or batch being offered.